GLOBAL BLOOD THERAPEUTICS for GLOBAL BLOOD THERAPEUTICS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Medicare and Medicaid Policy Drug Pricing ACA-related Issues Issues relating to FDA Approval Intellectual Property Tax issues, including tax reform, OD tax credit Trade issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI WAGNER New | — |
Trade (domestic/foreign) TRD
Medicare and Medicaid Policy Drug Pricing ACA-related Issues Issues relating to FDA Approval Intellectual Property Tax issues, including tax reform, OD tax credit Trade issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI WAGNER New | — |
Taxation/Internal Revenue Code TAX
Medicare and Medicaid Policy Drug Pricing ACA-related Issues Issues relating to FDA Approval Intellectual Property Tax issues, including tax reform, OD tax credit Trade issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI WAGNER New | — |
Health Issues HCR
Medicare and Medicaid Policy Drug Pricing ACA-related Issues Issues relating to FDA Approval Intellectual Property Tax issues, including tax reform, OD tax credit Trade issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI WAGNER New | — |
Medicare/Medicaid MMM
Medicare and Medicaid Policy Drug Pricing ACA-related Issues Issues relating to FDA Approval Intellectual Property Tax issues, including tax reform, OD tax credit Trade issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI WAGNER New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.